SLNO Insider Trading

Net Selling · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$429K
2 insiders
Net Insider Flow
-$429K
open market, 180d
Reporting Insiders
2
6 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Recent Form 4 Transactions

100 shown
DateInsiderRoleActionSharesPriceValue
May 18, 2026Volck BirgitteDirectorDisposed to issuer(D)10K
May 18, 2026Volck BirgitteDirectorDisposed to issuer(D)3K
May 18, 2026Volck BirgitteDirectorDisposed to issuer(D)3K
May 18, 2026Volck BirgitteDirectorDisposed to issuer(D)2K
May 18, 2026Volck BirgitteDirectorDisposed to issuer(D)3K
May 18, 2026Volck BirgitteDirectorDisposed to issuer(D)635
May 18, 2026Volck BirgitteDirectorDisposed to issuer(D)1K
May 18, 2026Volck BirgitteDirectorDisposed to issuer(D)18K
May 18, 2026Yen KristenSEE REMARKSDisposed to issuer(D)12K
May 18, 2026Anish BhatnagarCHIEF EXECUTIVE OFFICER, DirectorDisposed to issuer(D)584K
May 18, 2026Anish BhatnagarCHIEF EXECUTIVE OFFICER, DirectorDisposed to issuer(D)22K
May 18, 2026Anish BhatnagarCHIEF EXECUTIVE OFFICER, DirectorDisposed to issuer(D)60
May 18, 2026Bir Dawn CarterDirectorDisposed to issuer(D)17K
May 18, 2026Anish BhatnagarCHIEF EXECUTIVE OFFICER, DirectorDisposed to issuer(D)23K
May 18, 2026Anish BhatnagarCHIEF EXECUTIVE OFFICER, DirectorDisposed to issuer(D)35K
May 18, 2026Anish BhatnagarCHIEF EXECUTIVE OFFICER, DirectorDisposed to issuer(D)8K
May 18, 2026Anish BhatnagarCHIEF EXECUTIVE OFFICER, DirectorDisposed to issuer(D)73K
May 18, 2026Anish BhatnagarCHIEF EXECUTIVE OFFICER, DirectorDisposed to issuer(D)53K
May 18, 2026Anish BhatnagarCHIEF EXECUTIVE OFFICER, DirectorDisposed to issuer(D)201K
May 18, 2026Anish BhatnagarCHIEF EXECUTIVE OFFICER, DirectorDisposed to issuer(D)100K
May 18, 2026Anish BhatnagarCHIEF EXECUTIVE OFFICER, DirectorDisposed to issuer(D)116K
May 18, 2026Anish BhatnagarCHIEF EXECUTIVE OFFICER, DirectorDisposed to issuer(D)131K
May 18, 2026Manning MeredithChief Commercial OfficerDisposed to issuer(D)65K
May 18, 2026Manning MeredithChief Commercial OfficerDisposed to issuer(D)91K
May 18, 2026Manning MeredithChief Commercial OfficerDisposed to issuer(D)29K
May 18, 2026Manning MeredithChief Commercial OfficerDisposed to issuer(D)33K
May 18, 2026Fulk JenniferCHIEF FINANCIAL OFFICERDisposed to issuer(D)39K
May 18, 2026Fulk JenniferCHIEF FINANCIAL OFFICERDisposed to issuer(D)68K
May 18, 2026Hirano Patricia CSEE REMARKSDisposed to issuer(D)23K
May 18, 2026Hirano Patricia CSEE REMARKSDisposed to issuer(D)2K
May 18, 2026Hirano Patricia CSEE REMARKSDisposed to issuer(D)19K
May 18, 2026Hirano Patricia CSEE REMARKSDisposed to issuer(D)2K
May 18, 2026Hirano Patricia CSEE REMARKSDisposed to issuer(D)12K
May 18, 2026Hahn Mark WDirectorDisposed to issuer(D)10K
May 18, 2026Huang Michael F.Sr. VP of Clinical DevelopmentDisposed to issuer(D)40K
May 18, 2026Huang Michael F.Sr. VP of Clinical DevelopmentDisposed to issuer(D)110K
May 18, 2026Huang Michael F.Sr. VP of Clinical DevelopmentDisposed to issuer(D)14K
May 18, 2026Huang Michael F.Sr. VP of Clinical DevelopmentDisposed to issuer(D)12K
May 18, 2026Joshi ManherChief Development OfficerDisposed to issuer(D)20K
May 18, 2026Joshi ManherChief Development OfficerDisposed to issuer(D)72K
May 18, 2026Joshi ManherChief Development OfficerDisposed to issuer(D)5K
May 18, 2026Hirano Patricia CSEE REMARKSDisposed to issuer(D)49K
May 18, 2026Hirano Patricia CSEE REMARKSDisposed to issuer(D)16K
May 18, 2026Hirano Patricia CSEE REMARKSDisposed to issuer(D)14K
May 18, 2026Hirano Patricia CSEE REMARKSDisposed to issuer(D)12K
May 18, 2026Hirano Patricia CSEE REMARKSDisposed to issuer(D)1K
May 18, 2026Norrett KevinChief Business OfficerDisposed to issuer(D)18K
May 18, 2026Norrett KevinChief Business OfficerDisposed to issuer(D)64K
May 18, 2026Norrett KevinChief Business OfficerDisposed to issuer(D)4K
May 18, 2026Pauls MatthewDirectorDisposed to issuer(D)10K
May 18, 2026Pauls MatthewDirectorDisposed to issuer(D)9K
May 18, 2026Sinclair AndrewDirectorDisposed to issuer(D)10K
May 18, 2026Sinclair AndrewDirectorDisposed to issuer(D)1K
May 18, 2026Sinclair AndrewDirectorDisposed to issuer(D)823
May 18, 2026Sinclair AndrewDirectorDisposed to issuer(D)635
May 18, 2026Sinclair AndrewDirectorDisposed to issuer(D)3K
May 18, 2026Sinclair AndrewDirectorDisposed to issuer(D)2K
May 18, 2026Sinclair AndrewDirectorDisposed to issuer(D)3K
May 18, 2026Sinclair AndrewDirectorDisposed to issuer(D)3K
May 18, 2026Sinclair AndrewDirectorDisposed to issuer(D)10K
May 18, 2026Yen KristenSEE REMARKSDisposed to issuer(D)38K
May 18, 2026Yen KristenSEE REMARKSDisposed to issuer(D)2K
May 18, 2026Yen KristenSEE REMARKSDisposed to issuer(D)5K
May 18, 2026Yen KristenSEE REMARKSDisposed to issuer(D)4K
May 18, 2026Yen KristenSEE REMARKSDisposed to issuer(D)666
May 18, 2026Yen KristenSEE REMARKSDisposed to issuer(D)19K
May 18, 2026Yen KristenSEE REMARKSDisposed to issuer(D)2K
May 18, 2026Yen KristenSEE REMARKSDisposed to issuer(D)12K
May 18, 2026Yen KristenSEE REMARKSDisposed to issuer(D)55K
May 18, 2026Yen KristenSEE REMARKSDisposed to issuer(D)16K
May 18, 2026Yen KristenSEE REMARKSDisposed to issuer(D)14K
Mar 27, 2026Manning MeredithChief Commercial OfficerSell(S)558$31.72$18K
Mar 27, 2026Manning MeredithChief Commercial OfficerSell(S)2K$31.04$65K
Mar 27, 2026Manning MeredithChief Commercial OfficerSell(S)5K$30.04$146K
Mar 27, 2026Huang Michael F.Sr. VP of Clinical DevelopmentSell(S)4K$30.04$128K
Mar 27, 2026Huang Michael F.Sr. VP of Clinical DevelopmentSell(S)488$31.72$15K
Mar 27, 2026Huang Michael F.Sr. VP of Clinical DevelopmentSell(S)2K$31.04$57K
Mar 2, 2026Fulk JenniferCHIEF FINANCIAL OFFICERGrant(A)39K$0
Mar 2, 2026Fulk JenniferCHIEF FINANCIAL OFFICEROption exercise(M)68K$0
Jan 21, 2026Mackaness James HCHIEF FINANCIAL OFFICERGrant(A)29K$0
Jan 21, 2026Mackaness James HCHIEF FINANCIAL OFFICERGrant(A)33K$0
Jan 21, 2026Anish BhatnagarCHIEF EXECUTIVE OFFICER, DirectorGrant(A)114K$0
Jan 21, 2026Anish BhatnagarCHIEF EXECUTIVE OFFICER, DirectorGrant(A)131K$0
Jan 21, 2026Yen KristenSEE REMARKSGrant(A)10K$0
Jan 21, 2026Yen KristenSEE REMARKSGrant(A)12K$0
Jan 21, 2026Manning MeredithChief Commercial OfficerGrant(A)29K$0
Jan 21, 2026Manning MeredithChief Commercial OfficerGrant(A)33K$0
Jan 21, 2026Hirano Patricia CSEE REMARKSGrant(A)10K$0
Jan 21, 2026Hirano Patricia CSEE REMARKSGrant(A)12K$0
Jan 21, 2026Norrett KevinChief Business OfficerGrant(A)4K$0
Jan 21, 2026Norrett KevinChief Business OfficerGrant(A)4K$0
Jan 21, 2026Joshi ManherChief Development OfficerGrant(A)4K$0
Jan 21, 2026Joshi ManherChief Development OfficerGrant(A)5K$0
Jan 21, 2026Huang Michael F.Sr. VP of Clinical DevelopmentGrant(A)10K$0
Jan 21, 2026Huang Michael F.Sr. VP of Clinical DevelopmentGrant(A)12K$0
Dec 15, 2025Mackaness James HCHIEF FINANCIAL OFFICERTax withholding(F)2K$49.95$101K
Dec 15, 2025Anish BhatnagarCHIEF EXECUTIVE OFFICER, DirectorTax withholding(F)8K$49.95$381K
Dec 15, 2025Anish BhatnagarCHIEF EXECUTIVE OFFICER, DirectorGift(G)100K$0
Dec 15, 2025Yen KristenSEE REMARKSTax withholding(F)904$49.95$45K
Dec 15, 2025Manning MeredithChief Commercial OfficerTax withholding(F)2K$49.95$96K

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Coverage: Form 4 filings indexed 2021-03-292026-07-14. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).